Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Dr. Lal Pathlabs (DLPA.BO)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Rs)	Price Target (Rs)	Rating
2022-10-28	1282.88	1400.00	Buy
2023-02-06	983.78	1300.00	Buy
2023-05-11	953.40	1250.00	Buy
2023-09-18	1180.18	1400.00	Buy
2023-11-03	1296.70	1475.00	Buy
2024-03-21	1039.70	1450.00	Buy
2024-07-09	1462.00	1750.00	Buy
2024-11-08	1529.40	-	No Rating
2024-11-13	1482.13	1750.00	Buy
2025-01-30	1439.70	1675.00	Buy
2025-04-04	1257.30	1665.00	Buy
2025-07-31	1574.75	1850.00	Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.